CWA Asset Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.91M Buy
7,425
+666
+10% +$680K 0.27% 79
2026
Q1
$6.22M Buy
6,759
+40
+0.6% +$40.6K 0.21% 106
2025
Q4
$7.22M Buy
6,719
+849
+14% +$812K 0.26% 83
2025
Q3
$4.48M Sell
5,870
-1,366
-19% -$1.02M 0.17% 126
2025
Q2
$5.64M Buy
7,236
+281
+4% +$218K 0.24% 96
2025
Q1
$5.74M Buy
6,955
+161
+2% +$134K 0.28% 80
2024
Q4
$5.24M Buy
6,794
+724
+12% +$599K 0.26% 81
2024
Q3
$5.38M Buy
+6,070
New +$5.46M 0.29% 79
2024
Q1
$3.1M Buy
3,985
+713
+22% +$507K 0.19% 111
2023
Q4
$1.91M Buy
3,272
+807
+33% +$471K 0.13% 123
2023
Q3
$1.32M Buy
2,465
+300
+14% +$155K 0.1% 124
2023
Q2
$1.02M Buy
2,165
+556
+35% +$233K 0.07% 141
2023
Q1
$553K Buy
1,609
+163
+11% +$55K 0.04% 187
2022
Q4
$529K Buy
1,446
+323
+29% +$115K 0.04% 187
2022
Q3
$363K Buy
1,123
+43
+4% +$13.6K 0.04% 211
2022
Q2
$350K Buy
1,080
+293
+37% +$88K 0.03% 213
2022
Q1
$225K Buy
+787
New +$203K 0.02% 270
2019
Q1
Sell
-3,489
Closed -$404K 227
2018
Q4
$404K Buy
+3,489
New +$390K 0.09% 125

Other funds holding LLY

CWA Asset Management Group's LLY Position: Q2 2026 in Review

CWA Asset Management Group increased its Eli Lilly (LLY) stake by 9.9% in Q2 2026, buying an estimated $680K and bringing the position to 7,425 shares worth $8.91M. The position accounts for 0.27% of the portfolio, ranked #79.

CWA Asset Management Group first reported a position in LLY in Q4 2018 and has held it in 18 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • CWA Asset Management Group held 7,425 shares of Eli Lilly worth $8.91M as of Q2 2026.
  • CWA Asset Management Group bought 666 Eli Lilly shares in Q2 2026, an estimated $680K.
  • Eli Lilly made up 0.27% of CWA Asset Management Group's portfolio in Q2 2026, its #79 holding.
  • CWA Asset Management Group first reported a position in Eli Lilly in Q4 2018 and has held it in 18 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.